STOCK TITAN

Wearable Devices and Encord Sign Strategic Collaboration Agreement to Advance Neural-Enhanced Data for Physical AI

The agreement provides for device sales and usage-based compensation, with future commercial activity dependent on demand and implementation.

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
partnership AI

Wearable Devices (WLDS) signed a collaboration agreement with Encord to combine wrist-based neural sensing with visual data for Physical AI.

Led by Wearable Devices’ Kavana business unit, the collaboration aims to evaluate combined training data for robotics and other Physical AI applications. The agreement establishes a commercial framework for Encord to purchase devices and use collected data, with device sales and usage-based compensation for qualifying data-collection activity. Encord may provide datasets and processing outputs to third-party developers, subject to licensing, payment and commercialization terms.

Data collection, testing and integration are already underway. Future commercial activity depends on customer demand and implementation. The companies aim to assess whether neuromuscular signals can complement visual information when hands or objects are partly obscured.

Loading...
Loading translation...
3 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointEncord agreement establishes a commercial framework for device purchases and use of collected data.
  • Minor pointUsage-based compensation is provided for qualifying data-collection activity.
  • Minor pointData collection, testing and integration with Encord are already underway.

Negative

  • Moderate point. Forward-looking: it has not happened yet and may not happen.Future commercial activity depends on customer demand and implementation of the collaboration.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Joint development work would require separate written agreements.

News Explained

The signed agreement does not itself commit the companies to joint development; the release says any joint development work would require separate written agreements.

Key Terms

sEMG, occlusion
2 terms
sEMG technical
"captures surface electromyography (“sEMG”) signals associated with neuromuscular activity"
Surface electromyography (sEMG) is a noninvasive technique that records the electrical activity produced by muscles using sensors placed on the skin. For investors, sEMG indicates whether devices or therapies can objectively measure muscle function or track rehabilitation progress, making it a useful feature for medical devices, wearables and clinical studies; think of it as a stethoscope that listens to muscle signals rather than heart sounds.
occlusion technical
"particularly in scenarios involving occlusion, where fingers, hands or objects may be partially obscured"
Occlusion is the blocking or closing of a blood vessel or other bodily passage that reduces or stops normal flow—like a kink in a garden hose that prevents water from getting through. For investors, occlusion matters because it is the biological problem many drugs, medical devices and diagnostic tests are designed to treat or detect; its frequency, severity and how well treatments work affect clinical success, regulatory approval, market demand and potential revenue.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Collaboration aims to combine Wearable Devices’ Neural Intent data with Encord’s Physical AI data infrastructure to support richer multimodal training data for advanced Physical AI and robotics applications

YOKNEAM ILLIT, ISRAEL, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI”)-powered neural sensing wearables, today announced that it has entered into a strategic collaboration agreement with Cord Technologies, Inc. (“Encord”), an AI data infrastructure company focused on Physical AI.

The collaboration brings together Wearable Devices’ wrist-based neural sensing technology with Encord’s Physical AI data infrastructure and visual data capabilities, with the goal of creating richer multimodal training data for Physical AI systems. By combining neural signals associated with human movement and intent with visual information, the companies aim to enhance how Physical AI systems learn from and interpret complex human actions. On the Wearable Devices side, the collaboration is led by Kavana, the Company’s Physical AI business unit.

The agreement establishes a commercial framework for Encord to purchase Wearable Devices’ wrist-worn devices and use data collected through those devices, subject to the agreement’s licensing and commercialization terms. It builds on the companies’ existing evaluation relationship and supports their efforts to evaluate the combination of neural and visual information for Physical AI applications.

Wearable Devices’ wrist-worn technology, including Mudra Pro and Mudra Ultimate, captures surface electromyography (“sEMG”) signals associated with neuromuscular activity underlying hand and finger movement. The Company refers to this information as “Neural Intent” data, reflecting its potential use in interpreting movement-related intent rather than a direct measurement of a person’s thoughts or intentions.

This neuromuscular information is intended to complement vision-based data, particularly in scenarios involving occlusion, where fingers, hands or objects may be partially obscured from camera view. Such conditions can affect vision-based estimation of hand poses and movements. The collaboration aims to evaluate whether adding wrist-based sensing data can provide useful complementary information in these settings.

Combining neuromuscular and visual information may provide richer training data for dexterous hand manipulation and other advanced Physical AI applications. By adding synchronized neuromuscular signals to visual data, the companies aim to evaluate whether the combined data can provide a more complete representation of human hand movement and associated muscle activity than vision alone.

Under the collaboration, Encord may use data collected through Wearable Devices’ devices to create and provide datasets and other processing outputs to third-party developers, subject to the agreement’s licensing, payment and commercialization terms. The companies also intend to explore opportunities to support developers of Physical AI systems, humanoid robotics and advanced robotic manipulation applications. Any joint development work would be subject to separate written agreements.

The agreement provides for device sales and usage-based compensation to Wearable Devices for qualifying data-collection activity. Any future commercial activity will depend on customer demand and implementation of the collaboration.

The collaboration creates a potential pathway for providing Physical AI developers with differentiated training data that combines what a camera can observe with neuromuscular information associated with the underlying human action.

“Physical AI systems need increasingly rich data to understand not only what is happening in the physical world, but also the nuances of how human actions are performed,” said Leeor Langer, Chief Technology Officer of Wearable Devices. “Vision is a critical component of that process, while our Neural Intent technology can add another layer of information by capturing neuromuscular signals directly from the wrist. Together with Encord’s Physical AI data infrastructure, we believe this combination can create differentiated multimodal training data for increasingly sophisticated Physical AI and robotics systems.”

Langer continued, “Importantly, we are already working together on data collection, testing and integration. This collaboration represents another important step in extending our neural sensing technology beyond human-computer interaction and into the rapidly developing Physical AI ecosystem, while creating potential new commercial applications around the data generated by our technology.”

The collaboration supports Wearable Devices’ broader strategy of positioning its wrist-based neural sensing technology as an additional data layer for Physical AI, with the aim of complementing vision-based training data with synchronized information associated with human movement and muscle activation.

About Wearable Devices Ltd.

Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s Mudra products are defining the neural input category both for wrist-worn devices and for brain-computer interfaces, enabling touch-free, intuitive control of digital devices using gestures across multiple operating systems.

Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and XR, and provides enterprise partners with advanced input solutions for immersive and interactive environments. The ai6 Labs ecosystem accelerates this vision by integrating research, products, and AI breakthroughs. Expanding into Physical AI, the Company’s wearable neural sensing layer enriches human-generated training data for robotics and advanced physical systems; Kavana is the Company’s Physical AI business unit - for more information, visit kavana.tech. Wearable Devices’ ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols “WLDS” and “WLDSW,” respectively.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable U.S. federal securities laws. Forward-looking statements include statements regarding the anticipated implementation and expansion of the collaboration between Wearable Devices and Encord; planned data collection, testing and integration; the potential benefits of combining neuromuscular and visual information; the quality and potential uses of multimodal training datasets and other processing outputs; potential applications in Physical AI and robotics; potential demand from third-party developers; and potential future device sales, usage-based compensation and other commercial opportunities.

Forward-looking statements are based on current expectations, assumptions and beliefs and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, among others, the ability of the parties to implement and maintain the collaboration and successfully collect, synchronize and combine neuromuscular and visual data; whether the resulting data provides the anticipated technical benefits; the technical performance and commercial acceptance of resulting datasets, products or services; the ability to agree on additional commercial terms and obtain approvals where required; compliance with applicable privacy, biometric-data and other laws and the availability of required participant consents and third-party rights; market demand for Physical AI solutions; competition; technological developments; and the other risks and uncertainties described in Wearable Devices’ filings with the U.S. Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on forward-looking statements. Wearable Devices undertakes no obligation to update any forward-looking statement except as required by applicable law.

Investor Relations Contact: Michal Efraty

IR@wearabledevices.co.il


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How could Wearable Devices earn revenue from its Encord collaboration?

The agreement provides for device sales and usage-based compensation to Wearable Devices for qualifying data-collection activity. It establishes a framework for Encord to purchase wrist-worn devices and use collected data, subject to licensing and commercialization terms. Future commercial activity depends on customer demand and implementation.

Does Wearable Devices’ Neural Intent technology measure thoughts?

Wearable Devices’ Neural Intent data is not a direct measurement of thoughts or intentions. Its wrist-worn technology captures surface electromyography signals, meaning electrical signals associated with neuromuscular activity underlying hand and finger movement. The name reflects the data’s potential use in interpreting movement-related intent.

Does the Wearable Devices and Encord agreement cover joint development work?

Any joint development work would be subject to separate written agreements. The companies intend to explore opportunities to support developers of Physical AI systems, humanoid robotics and advanced robotic manipulation applications.

Keep reading